All-Trans Retinoic Acid supplementation prevents cardiac fibrosis and cytokines induced by Methylglyoxal
- 14 January 2017
- journal article
- research article
- Published by Springer Nature in Glycoconjugate Journal
- Vol. 34 (2) , 255-265
Abstract
Methylglyoxal (MG), a metabolic intermediate of glycolysis is a precursor for endogeneous production of advanced glycation end-products. The increased production of MG have negative influence over the structure and function of different biomolecules and thus plays an important role in the pathogenesis of diabetic cardiac complications. Retinoic acid (RA), an active metabolite of vitamin A, has a major role in preventing cardiac remodeling and ventricular fibrosis. Hence, the objective of the present study was to determine whether rats administered with all-trans retinoic acid (RA) could attenuate MG induced pathological effects. Wistar rats were divided into 4 groups. Group 1 rats were kept as control; Group 2 rats were administrated with MG (75 mg/kg/day) for 8 weeks. Group 3 rats were given RA (Orally, 1.0 mg/kg/day) along with MG; Group 4 rats received RA alone. Cardiac antioxidant status, induction of fibrosis, AGE receptor (RAGE) and cytokines expression was evaluated in the heart tissues. Administration of MG led to depletion of antioxidant enzymes, induction of fibrosis (p < 0.001), up-regulated expression of RAGE (3.5 fold), TGF-β (4.4 fold), SMAD2 (3.7 fold), SMAD3 (6.0 fold), IL-6 (4.3 fold) and TNF-α (5.5 fold) in the heart tissues compared to control rats. Moreover, the exogenous administration of MG caused significant (p < 0.001) increase in the circulating CML levels. Whereas, RA treatment prevented the induction of fibrosis and restored the levels of cytokines and RAGE expression. Methylglyoxal-induced fibrosis can lead to pathological effects in the heart tissues. RA attenuates the effects of MG in the heart, suggesting that it can be of added value to usual diabetic therapy.Keywords
Funding Information
- Anusandhan National Research Foundation (SB/YS/LS-385/2013)
This publication has 21 references indexed in Scilit:
- Reduction of Methylglyoxal-Induced Glycation by Pyridoxamine Improves Adipose Tissue Microvascular LesionsJournal of Diabetes Research, 2013
- Advanced glycation end productsDermato-Endocrinology, 2012
- The expression of the receptor for advanced glycation end-products (RAGE) in RA-FLS is induced by IL-17 via Act-1Arthritis Research & Therapy, 2011
- Oxidative Stress and Diabetic ComplicationsCirculation Research, 2010
- Methylglyoxal, glyoxalase 1 and the dicarbonyl proteomeAmino Acids, 2010
- Advanced glycation endproducts: from precursors to RAGE: round and round we goAmino Acids, 2010
- Hyperglycemia and Glycation in Diabetic ComplicationsAntioxidants & Redox Signaling, 2009
- Phospho-control of TGF-β superfamily signalingCell Research, 2008
- Signaling cross-talk between TGF-β/BMP and other pathwaysCell Research, 2008
- Mitogen-activated Protein Kinases and Mitogen-activated Protein Kinase Phosphatases Mediate the Inhibitory Effects of All-trans Retinoic Acid on the Hypertrophic Growth of CardiomyocytesJournal of Biological Chemistry, 2004